Is a 6 mm hyperdense (≈665 HU) stone in the left proximal ureter with moderate hydronephrosis suitable for extracorporeal shock‑wave lithotripsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ESWL is Appropriate for This 6mm Proximal Ureteral Stone

Yes, this 6mm hyperdense stone (665 HU) in the left proximal ureter with moderate hydronephrosis is indicated for ESWL, though the stone density suggests you should counsel the patient about potentially reduced fragmentation efficiency and consider ureteroscopy as an equally appropriate first-line alternative.

Stone Size and Location Support ESWL

  • For proximal ureteral stones ≤10mm, both ESWL and ureteroscopy are acceptable first-line treatment options 1, 2.
  • ESWL achieves an 82% stone-free rate for proximal ureteral stones overall, with additional procedures required in only 0.62 procedures per patient 1.
  • The 6mm size falls well within the optimal range for ESWL, as stones <10mm demonstrate 90% stone-free rates 1.

Stone Density is a Critical Consideration

The 665 HU density is moderately concerning but not prohibitive for ESWL success:

  • Stones with attenuation values <500 HU achieve 100% clearance with ESWL, while those 500-1000 HU achieve 95.7% clearance 3.
  • Your stone at 665 HU falls in the favorable middle range where ESWL remains highly effective 3.
  • Stones ≥956 HU are not ideal candidates for ESWL, but your stone is well below this threshold 3.
  • Higher density stones (cystine, brushite, calcium oxalate monohydrate) demonstrate reduced fragmentation, though the specific composition matters more than density alone 1.

Hydronephrosis Does Not Negatively Impact ESWL Success

  • The presence and degree of hydronephrosis does not affect ESWL success rates or time to stone clearance for proximal ureteral stones 4.
  • In a study of 130 patients with proximal ureteral stones, stone-free rates were 74.4% regardless of hydronephrosis severity (none, mild, moderate, or severe) 4.
  • The moderate hydronephrosis in this case should not deter you from offering ESWL 4.

Alternative Treatment: Ureteroscopy

If you anticipate the stone density may compromise ESWL efficiency, ureteroscopy offers superior stone-free rates:

  • Ureteroscopy achieves 81% stone-free rates for proximal ureteral stones with the majority rendered stone-free in a single procedure 1.
  • Modern holmium:YAG laser technology readily fragments high-density stones that resist shock-wave energy 1.
  • Complication rates for ureteroscopy are low (<5% perforation, <2% stricture) 1.

Treatment Algorithm for This Case

Proceed with ESWL as first-line if:

  • Patient prefers minimal anesthesia (ESWL can be performed with IV sedation) 1
  • Patient accepts potential for repeat procedures
  • No contraindications exist (pregnancy, bleeding disorders) 2

Consider ureteroscopy as first-line if:

  • Patient prioritizes single-procedure stone clearance
  • Stone composition analysis suggests resistant stone type
  • Patient has failed prior ESWL

Important Caveats

  • Rule out infection before any intervention - if sepsis or anuria is present, urgent decompression via nephrostomy or stent is required before definitive treatment 2.
  • Routine stenting before ESWL offers no advantage and is not recommended 1.
  • Fluoroscopic targeting is preferred over ultrasound for ureteral stones to ensure accurate shock-wave focusing 1.
  • Expect stone passage within 28 days if ESWL is successful, with 90% of stone-free cases clearing fragments in this timeframe 5.

Related Questions

What is the treatment for a 5x4 millimeter vesicoureteric junction stone with a density of 1247 Hounsfield Units (HU), indicated for Ureteroscopic Lithotripsy (lithotripsy using a Ureteroscope)?
What is the management for a 4 mm stone in the distal ureter with mild hydronephrosis?
What is the role of the Guy's Stone Score in determining the best treatment approach for an adult patient with a kidney stone?
What is the management approach for a patient with a renal stone and hydronephrosis?
What is the best treatment option for a patient with a proximal ureteric stone causing mild-moderate hydronephrosis, considering flexible ureteroscopy or Extracorporeal Shock Wave Lithotripsy (ESWL)?
Where do ziprasidone and melperone rank among antipsychotics in terms of risk of drug‑induced Parkinsonism?
What HCPCS code should be used to bill a Medicare annual wellness visit for a new patient versus an established patient?
What alternative contraceptive method would best control heavy irregular menstrual bleeding in a young female with normal hemoglobin, low‑normal ferritin, painful cramping while on depot medroxyprogesterone (Depo‑Provera) and no prior ultrasound evaluation?
What is the recommended treatment approach for trigeminal neuralgia, including first‑line medications, alternatives, and surgical options?
What supplements and complementary and alternative medicine (CAM) therapies can aid weight loss in a 6‑month postpartum woman who stopped breastfeeding 2 weeks ago, is taking levothyroxine 25 micrograms daily with occasional missed doses, restarted fluoxetine (Prozac) 2 weeks ago, and presents with fatigue, low mood, low motivation, difficulty losing weight, and new snoring?
How should I classify allergic rhinitis (intermittent vs persistent, mild/moderate/severe) and what is the recommended stepwise pharmacologic management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.